New drug aims to keep aggressive lung cancer at bay

NCT ID NCT03706690

Ongoing Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study tested whether a drug called durvalumab could help control Stage III non-small cell lung cancer that cannot be surgically removed. About 400 patients who had completed chemoradiation without their cancer getting worse received either durvalumab or a placebo. The main goal was to see if the drug could delay the cancer's return or progression.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Research Site

Beijing, 100021, China
Research Site

Beijing, 100142, China
Research Site

Beijing, 100730, China
Research Site

Beijing, 100853, China
Research Site

Bengbu, 233004, China
Research Site

Changchun, 130000, China
Research Site

Changsha, 410013, China
Research Site

Chengdu, 610041, China
Research Site

Chengdu, 610042, China
Research Site

Chengdu, 610072, China
Research Site

Chongqing, 400037, China
Research Site

Fuzhou, 350011, China
Research Site

Guangzhou, 510100, China
Research Site

Guangzhou, 510280, China
Research Site

Hangzhou, 310003, China
Research Site

Hangzhou, 310006, China
Research Site

Hangzhou, 310022, China
Research Site

Harbin, 150081, China
Research Site

Linhai, 317000, China
Research Site

Nanjing, 210009, China
Research Site

Nanning, 530021, China
Research Site

Ningbo, 315010, China
Research Site

Qingdao, 266042, China
Research Site

Shanghai, 200030, China
Research Site

Shanghai, 200032, China
Research Site

Shanghai, 200433, China
Research Site

Shenyang, 110042, China
Research Site

Ürümqi, 830000, China
Research Site

Wenzhou, 325000, China
Research Site

Wuhan, 430030, China
Research Site

Yangzhou, 225001, China
Research Site

Zhengzhou, 450000, China
Research Site

Zhengzhou, 450008, China
Research Site

Hong Kong, 00000, Hong Kong
Research Site

Bangalore, 560068, India
Research Site

Bengaluru, 560076, India
Research Site

Karamsad, 388325, India
Research Site

Kolkata, 700160, India
Research Site

Nashik, 422005, India
Research Site

Vadodara, 390007, India
Research Site

Culiacán, 80230, Mexico
Research Site

Mexico City, 0 3100, Mexico
Research Site

Mexico City, 11810, Mexico
Research Site

México, 1400, Mexico
Research Site

Monterrey, 64000, Mexico
Research Site

San Luis Potosí City, 78250, Mexico
Research Site

Bacolod, 6100, Philippines
Research Site

Baguio City, 2600, Philippines
Research Site

Cagayan de Oro, 9000, Philippines
Research Site

Cebu, 6000, Philippines
Research Site

Davao City, 8000, Philippines
Research Site

Quezon City, 1100, Philippines
Research Site

Quezon City, 1104, Philippines
Research Site

San Juan City, 1502, Philippines
Research Site

Bialystok, 15-540, Poland
Research Site

Gdansk, 80-952, Poland
Research Site

Poznan, 60-569, Poland
Research Site

Tomaszów Mazowiecki, 97-200, Poland
Research Site

Warsaw, 02-781, Poland
Research Site

Kazan, Tatarstan, 420029, Russia
Research Site

Kirov, 610021, Russia
Research Site

Moscow, 115478, Russia
Research Site

Moscow, 121467, Russia
Research Site

Murmansk, 183047, Russia
Research Site

Novosibirsk, 630055, Russia
Research Site

Novosibirsk, 630099, Russia
Research Site

Obninsk, 249036, Russia
Research Site

Saint Petersburg, 197758, Russia
Research Site

Samara, 443031, Russia
Research Site

Saransk, 430005, Russia
Research Site

Volgograd, 400138, Russia
Research Site

Daegu, 41944, South Korea
Research Site

Gwangju, 61469, South Korea
Research Site

Seoul, 08308, South Korea
Research Site

Taichung, 40705, Taiwan
Research Site

Tainan, 70403, Taiwan
Research Site

Taipei, 10002, Taiwan
Research Site

Taipei, 11217, Taiwan
Research Site

Taipei, 114, Taiwan
Research Site

Taipei, 235, Taiwan
Research Site

Taoyuan District, 333, Taiwan
Research Site

Adana, 01060, Turkey (Türkiye)
Research Site

Ankara, 06340, Turkey (Türkiye)
Research Site

Edirne, 22030, Turkey (Türkiye)
Research Site

Istanbul, 34030, Turkey (Türkiye)
Research Site

Konya, 42080, Turkey (Türkiye)
Research Site

Malatya, 44100, Turkey (Türkiye)

Conditions

Explore the condition pages connected to this study.

CARCINOMA, NON-SMALL-CELL LUNG